These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 21427388

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Tuberculosis retreatment category predicts resistance in hospitalized retreatment patients in a high HIV prevalence area.
    Schreiber YS, Herrera AF, Wilson D, Wallengren K, Draper R, Muller J, Dawood H, Doucette S, Cameron DW, Alvarez GG.
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1274-80. PubMed ID: 19793433
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A high prevalence of resistance in new tuberculosis cases of midwestern Brazil.
    Santos LC, Bousquet Hde M, Pereira AM, Junqueira-Kipnis AP, Kipnis A.
    Infect Genet Evol; 2010 Oct; 10(7):1052-7. PubMed ID: 20619356
    [Abstract] [Full Text] [Related]

  • 28. Exploring tuberculosis patients' adherence to treatment regimens and prevention programs at a public health site.
    Naidoo P, Dick J, Cooper D.
    Qual Health Res; 2009 Jan; 19(1):55-70. PubMed ID: 18997153
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Can a nine-month regimen be used to treat isoniazid resistant tuberculosis diagnosed after standard treatment is started?
    Ormerod LP, Horsfield N, Green RM.
    J Infect; 2001 Jan; 42(1):1-3. PubMed ID: 11243745
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Current treatment of tuberculosis].
    García Ramos R, Lado Lado FL, Túnez Bastida V, Pérez del Molino Bernal ML, Cabarcos Ortiz de Barrón A.
    An Med Interna; 2003 Feb; 20(2):91-100. PubMed ID: 12703164
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Current situation of contacts examination and chemoprophylaxis for persons exposed to multi-drug resistant tuberculosis in ordinance-designated cities in Japan].
    Sasaki Y, Yamagishi F, Yagi T.
    Kekkaku; 2005 Oct; 80(10):637-42. PubMed ID: 16296391
    [Abstract] [Full Text] [Related]

  • 37. Risk of relapse and failure after retreatment with the Category II regimen in Nepal.
    Yoshiyama T, Shrestha B, Maharjan B.
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1418-23. PubMed ID: 20937181
    [Abstract] [Full Text] [Related]

  • 38. Contact screening and chemoprophylaxis in India's Revised Tuberculosis Control Programme: a situational analysis.
    Banu Rekha VV, Jagarajamma K, Wares F, Chandrasekaran V, Swaminathan S.
    Int J Tuberc Lung Dis; 2009 Dec; 13(12):1507-12. PubMed ID: 19919768
    [Abstract] [Full Text] [Related]

  • 39. Quality of tuberculosis care in six health facilities of Afar Region, Ethiopia.
    Girma A, H/Mariam D, Deribe K.
    Ethiop Med J; 2010 Jul; 48(3):195-202. PubMed ID: 21073080
    [Abstract] [Full Text] [Related]

  • 40. TB contact investigations: 12 years of experience in the National TB Programme, Morocco 1993-2004.
    Ottmani S, Zignol M, Bencheikh N, Laâsri L, Blanc L, Mahjour J.
    East Mediterr Health J; 2009 Jul; 15(3):494-503. PubMed ID: 19731765
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.